PLUR PLURI INC
-
PLURI INC Reported Earnings
Thursday, May 14, 2026 · 12:00 AM ET
PLURI INC (PLUR) reported a loss of $0.55 per share on revenue of $0.17 million for the . . Revenue fell 60.89% compared to the same quarter a year ago.
Pluri Inc. is a biotechnology company. Its technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of medicine and climate change to food scarcity, animal cruelty and beyond. Pluri Inc., formerly known as Pluristem Therapeutics Inc., is based in HAIFA, Israel.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.55)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
$0.17M
Revenue Estimate
—
Revenue Surprise
Revenue Growth